The discovery of bretylium and bethanidine.
- 1 January 1982
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 13 (1) , 25-34
- https://doi.org/10.1111/j.1365-2125.1982.tb01333.x
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- HISTORICAL PERSPECTIVE NORADRENERGIC NEURONE BLOCKING AGENTSJournal of Autonomic Pharmacology, 1981
- Adrenergic Neurone Blocking AgentsAnnual Review of Pharmacology, 1965
- Reserpine-induced release of drugs from sympathetic nerve endingsLife Sciences, 1964
- ADRENERGIC NEURONE-BLOCKING AGENTSThe Lancet, 1962
- Structural requirements for bretylium and guanethidine-like activity in a series of guanidine derivativesLife Sciences, 1962
- Adrenergic Neurone-blocking Agents related to Choline 2,6-Xylyl Ether Bromide (TM 10), Bretylium and GuanethidineNature, 1961
- Hypotensive action of bretylium tosylate (Darenthin)American Heart Journal, 1960
- CLINICAL PHARMACOLOGY OF BRETYLIUM TOSYLATE: PRELIMINARY OBSERVATIONSAnnals of the New York Academy of Sciences, 1960
- Selective Inhibition of the Sympathetic Nervous System in Man with Bretylium Tosylate, a New Antihypertensive AgentCirculation, 1960
- Powerful Adrenergic Neurone-blocking Agents related to Choline 2,6-Xylyl Ether BromideNature, 1960